Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 92 for “"Adenoviral vector"”.
-
Development of an adenoviral vector vaccine for Rhodococcus equi
Rhodococcus equi (R. equi) (Prescottella equi) is a major respiratory pathogen of foals. Virulence is associated with plasmid encoded virulence associated proteins, all of which contribute towards its pathogenicity in foals. The virulence plasmid in R. equi contains a conserved pathogenicity island …
-
Development of an Adenoviral Vector Platform for Selective Gene Delivery to Neurons
… therapy delivery to humans in clinical trials. A vector platform capable of delivering current and future therapeutics in a targeted manner--particularly to neurons--would ease this burden. Such a platform must be capable of targeted gene delivery as well as a large genetic capacity so payloads …
-
OAdV7, an ovine adenoviral vector as a novel vaccine vector for tumour immunotherapy
… making them one of the most popular viral vectors for vaccine development. To date, the majority of the studies in the literature have focused upon human adenovirus serotype 5 (HAdV5) for the development of adenoviral vectors. However, the use of HAdV5 is limited due to its high prevalence …
-
Development of an adenoviral vector expressing glucagon-like peptide-1 for gene therapy in diabetes
… vivo GLP-1 gene transfer to the liver using an adenoviral vector expressing GLP-1 and its effects on glucose homeostasis in diabetic db/db mice was examined. A replication-deficient adenoviral vector was constructed to express DPIVresistant GLP-1 under the regulation of a liver-specific, …
-
Development of a Genome-Replicating High-Capacity Adenoviral Vector for Enhanced In Situ Payload Expression
… for continuous recombinant therapeutic supply. Adenoviral vectors are the most commonly used viral gene delivery vectors to mediate such in situ expression of protein-based therapeutics. While they are in clinical use for more than 30 years, their application is still limited by three major …
-
Evaluating the Interaction of Platelet Factor 4 and Adenoviral Vector-Based SARS-CoV-2 Vaccines in the Pathogenesis of Vaccine-Induced Immune Thrombotic Thrombocytopenia
The widespread use of adenoviral (AdV)-based SARS-CoV-2 vaccines, such as ChAdOx1-S (AstraZeneca) and Ad26.COV2.S (Johnson & Johnson/Janssen), has been crucial in combating the COVID-19 pandemic. However, these vaccines have been linked to vaccine-induced immune thrombotic thrombocytopenia (VITT), …
-
Modulating the CXCL12/CXCR4 Axis in the Pulmonary Vasculature by Adenoviral Vector-Mediated Delivery of soluble CXCR4 (sCXCR4): A Prophylactic Approach to the Prevention of Cancer Metastasis to the Lung
The results also indicate that in situ nests were cooler than egg corral nests but still
-
Determination of Methods for Improved Reprogramming of Various Cell Types to Functional Beta-like Cells
… Ngn3 and MafA) incorporated in a polycistronic adenoviral vector system (Ad-PNM) was used to directly reprogram cells to beta-like cells that produce insulin in vitro. In addition, the role of innate immunity activation and open chromatin structure during reprogramming is studied to improve …
-
Generation of both an shRNA-resistant MEF2A over expression construct and a dominant negative construct in adenovirus for rescue and knockout experiments in muscle
… MEF2A over expression construct in an adenoviral vector was created to perform rescue experiments. Second, to compare individual MEF2 isoform knockouts to a complete knockout of the entire MEF2 family, a dominant negative construct was created in an adenoviral vector. In both cases, a …
-
Development of a Protein-Based Therapy for the Treatment of Spinal Muscular Atrophy
… develop a protein-based therapy for SMA using an adenoviral vector which encodes a secretable form of SMN fused to a protein transduction domain (PTD) derived from the trans-acting activator of transcription (TAT) from HIV. We generated secretable GFP proteins using transient transfection in …
-
Synergistic effect between human vascular endothelial growth factor and angiopoietin-1 combined with myoblast therapy for treatment of ischemically damaged hind limbs
… single administration using a novel bicistronic adenoviral vector that was carried in myoblasts. Extensive in vivo survival of transplanted myoblasts was observed in the ischemic limb, with angiographic evidence of enhanced neovascularization in the treated group. This was confirmed by …
-
Development of adenoviral vectors for monitoring telomerase activity in living cells
… in cells. Moreover, we chose to work with adenoviral vectors due to their high level of transient gene expression as a gene transfer system. Unfavourably, adenoviral vector transduction of tumour cells has been hampered by low expression of the coxsackie B and adenovirus receptor (CAR) on …
-
Paracrine Adenoviral Delivery of Therapeutic Payloads for Cancer Therapy
Adenoviral vectors are the most commonly used delivery vectors for clinical gene therapy due to their favorable characteristics: (i) they do not integrate into the host cell genome and thus harbor a reduced risk of insertional mutagenesis, (ii) they efficiently transduce dividing and non-dividing …
-
Adenovirus-based gene therapy approaches for hemophilia B
… in gene therapeutic approaches. Several viral vectors were tested for the treatment of hemophilia B. The administration of an episomal adenoviral vector at non-toxic dose showed effective phenotypic correction, but the therapeutic effect was only transient. Therefore, the combination of …
-
Direct reprogramming of non-human primate bile ducts in vivo and human pancreatic ductal cells in vitro towards a B-cell state
… Ngn3, and MafA when expressed together by an adenoviral vector (Ad-PNM) are able to directly reprogram Sox9+ cells lining the bile ducts of mice into insulin expressing cells that restore glucose homeostasis in diabetic mice. As an extension of this work, in this research project Ad-PNM was …
-
Fusogenic membrane glycoproteins as a gene therapy for cancer
… This was independent of the cell cycle. Viral vectors expressing FMG were developed. There was inefficient production of retroviral vectors based on the Moloney murine leukaemia virus expressing GALV. Improved titre was seen from a lentiviral vector expressing GALV. This vector, when injected …
Page 1 of 5